Bacteriophage protein could make queso fresco safer
A slice of queso fresco might seem harmless, but in some instances, it can carry a deadly hitchhiker: Listeria monocytogenes. As Hispanic-style cheeses gain popularity in U.S. kitchens, scientists are working to ensure their safety. Traditional methods to curb Listeria have limits, so researchers are turning to an unexpected ally: viruses that hunt bacteria.

In the battle against foodborne illness, scientists are turning to an unlikely ally: bacteriophages, viruses that infect bacteria. A recent Journal of Biological Chemistry details the structure and function of PlyP100, an endolysin from bacteriophage P100.
Researchers from the labs of , professor of food microbiology at the University of Illinois Urbana–Champagne, and , professor of biochemistry at Stockholm University, combined their expertise in food safety and novel protein characterization to study PlyP100. Co-first authors Karson Bateman and Emma Scalleti Hutchinson said the P100 bacteriophage is already used in food production, so PlyP100 could be commercialized to prevent Listeria in queso fresco.
PlyP100 is an endolysin, a protein bacteriophages use to break down bacterial cell walls.
"With Gram-positive bacteria, it is possible for endolysins to hydrolyze the surface exposed peptidoglycan when added exogenously which makes then an interesting tool for controlling unwanted, Gram-positive bacteria," Miller said.
Few endolysins have been studied in detail, so identifying the best candidates for food safety remains trial and error, Bateman said. To move beyond trial and error, the team used AlphaFold to predict PlyP100’s 3D structure, revealing three domains.
Domain 1 proved key for hydrolytic activity, the team confirmed by testing mutated versions in lab models, including queso fresco. They found domain 3 binds Listeria’s cell wall and discovered an unexpected role for domain 2.
“The second domain does not seem to have a discrete function, yet it is still necessary for full function of the endolysin," Scaletti said. "The importance of domain 2 was a bit of a surprise but this demonstrates why experimental validation is still needed.”
This structural insight could enable computer-based analysis of uncharacterized endolysins and expand their use.
"We anticipate that work like this will enable analysis of uncharacterized endolysins identified in genomic sequence databases and facilitate greater application of these powerful proteins," Stenmark said.
Next, the team plans to produce PlyP100 in a GRAS, or a Generally Recognized as Safe, organism, such as yeast, to test conditions to keep it active in queso fresco and study synergy with other antimicrobials.
Food safety affects everyone, from farmers to families at the dinner table. By unlocking the secrets of PlyP100, researchers are moving beyond trial and error toward precision tools that could stop deadly outbreaks before they start. If successful, this work won’t just protect queso fresco lovers — it could redefine how we safeguard the global food supply.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.

Gut microbes hijack cancer pathway in high-fat diets
Researchers at the Feinstein Institutes for Medical Research found that a high-fat diet increases ammonia-producing bacteria in the gut microbiome of mice, which in turn disrupts TGF-β signaling and promotes colorectal cancer.

Mapping fentanyl’s cellular footprint
Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl’s effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.

Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Cholesterol as a novel biomarker for Fragile X syndrome
Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.

How lipid metabolism shapes sperm development
Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.